These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6237903

  • 1. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL, Mumtaz G, Gabriel FG, Oriel JD.
    Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
    [Abstract] [Full Text] [Related]

  • 2. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P, Renaudin H, Quentin C, Bebear C.
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH, Wagenvoort JH, van Klingeren B, Piot P, Stolz E, Michel MF.
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [Abstract] [Full Text] [Related]

  • 4. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
    Dobson RA, O'Connor JR, Poulin SA, Kundsin RB, Smith TF, Came PE.
    Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD, Saunders J, Fehler G, Ballard RC, Koornhof HJ.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
    Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J.
    Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
    [Abstract] [Full Text] [Related]

  • 12. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986 Jan; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW, Muytjens HL.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):123-4. PubMed ID: 6230988
    [Abstract] [Full Text] [Related]

  • 14. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
    Bébéar CM, de Barbeyrac B, Pereyre S, Renaudin H, Clerc M, Bébéar C.
    Clin Microbiol Infect; 2008 Aug; 14(8):801-5. PubMed ID: 18727805
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Aug; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 16. Comparative in-vitro activity of sparfloxacin against genital pathogens.
    Perea EJ, Aznar J, Garcia-Iglesias MC, Pascual A.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
    [Abstract] [Full Text] [Related]

  • 17. Antichlamydial activity of quinolone carboxylic acids.
    Heppleston C, Richmond S, Bailey J.
    J Antimicrob Chemother; 1985 May; 15(5):645-7. PubMed ID: 3159713
    [No Abstract] [Full Text] [Related]

  • 18. Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the disease.
    Hawkins DA, Taylor-Robinson D, Evans RT, Furr PM, Harris JR.
    Genitourin Med; 1985 Feb; 61(1):51-5. PubMed ID: 3910541
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Freeman S, Wormuth J, Cornett J.
    Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
    [No Abstract] [Full Text] [Related]

  • 20. Activities of new quinoline derivatives against genital pathogens.
    Aznar J, Caballero MC, Lozano MC, de Miguel C, Palomares JC, Perea EJ.
    Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.